Sites, subjects, and visits—trial operations with monitoring and document control that sponsors and CROs can inspect.

Run trials with traceability—scheduling, deviations, and monitoring visits under control

We model protocols, arms, and visit schedules with CRUD permissions by role. Query management ties to data clarification; essential documents live in controlled repositories with version and signature expectations. Integration hooks push data to EDC partners where CTMS remains system of operational truth.

Request Estimate
Clinical Trial Management (CTMS) Software Development

01 // THE MANDATE

Sites, subjects, and visits—trial operations with monitoring and document control that sponsors and CROs can inspect.

We model protocols, arms, and visit schedules with CRUD permissions by role. Query management ties to data clarification; essential documents live in controlled repositories with version and signature expectations.

Integration hooks push data to EDC partners where CTMS remains system of operational truth.

02 // ENGINEERING

Development process

Structured phases—from discovery to launch—with clear ownership and handoff points.

Protocol intake (weeks 1–4)

Roles, visit schedule, pilot sites.

Core CTMS (weeks 4–16)

Enrollment, visits, monitoring MVP.

Validation (weeks 12–22)

IQ/OQ/PQ patterns; SOP alignment.

Go-live (weeks 20–26)

First studies live; sponsor training.

Operate (ongoing)

Protocol amendments; audits; new sites.

03 // CAPABILITIES

Core Capability Matrix

The building blocks of your solution

Studies

protocol versions, sites, investigators.

Subjects

enrollment, consent tracking, visit windows.

Visits

procedures, labs, imaging expectations.

Monitoring

SDV plans, findings, CAPA tracking.

Deviations

log, severity, reporting timelines.

Documents

eTMF handoffs; audit trail.

Supplies

IP shipment tracking hooks.

Reporting

enrollment curves, query aging, site performance.

Compliance

21 CFR Part 11 patterns with validation plan.

API

EDC, IRT partners optional.

04 // DELIVERY LIFECYCLE

The strategic roadmap

Milestones and checkpoints—each phase has a clear outcome before the next begins.

Milestone 01Delivery

Weeks 1–4: Charter, validation plan.

Milestone 02Delivery

Weeks 5–14: Sandbox study execution.

Milestone 03Delivery

Weeks 12–20: Monitoring depth; eTMF bridge.

Milestone 04Delivery

Weeks 19–26: Production studies.

Milestone 05Delivery

Ongoing: Multi-study portfolio; analytics.

05 // PRODUCT SCOPING

Choosing your path

Two engagement models—start lean and iterate, or commit to a full platform build from day one.

MVP

Speed & essentialism

Phase 1
MVP: single study, sites, subjects, visit tracking, monitoring log, document list. Excludes full EDC, IRT, and Part 11 full validation unless scoped. Proves ops before enterprise pharma.
Recommended

Full product

Enterprise maturity

All-in
Enterprise CTMS: portfolio analytics, risk-based monitoring, full Part 11, global sites.

06 // PARTNERSHIP

Why work together

A single accountable partner across strategy, build, and go-live—not a revolving door of vendors.

John Hambardzumian
Direct collaboration

End-to-end ownership: discovery, architecture, implementation, and launch—with clear communication and production-grade engineering.

  • Discovery & alignment
  • Systems that scale
  • Implementation depth
  • Clear comms

07 // CLARITY

Frequently asked

CTMS for operations; EDC for CRF data—integrations are explicit.

Ready to start?

Tell me about your product goals and timeline—I'll respond with a clear path forward.